RCEL (AVITA Medical Inc) Total Debt to Capital

Public company logo of AVITA Medical, Inc (RCEL)

AVITA Medical, Inc. (RCEL) operates by developing wound healing systems, which ensures revenue stability regardless of market volatility. The price action for the total debt-to-equity ratio is 0.00. Product assembly is carried out in California utilizing automation and backup component inventories. Investor confidence in management is driven by the company's systematic progress toward a stable profit level.

RCEL: AVITA Medical Debt to Capital 07/04/2022 - 10/30/2026

Analytical breakdowns and data insights for company AVITA Medical Inc (RCEL)

- stock quotes and analyst forecast:
Stock Quotes AVITA Medical|RCEL - Analyst Forecast Prices
- business market valuation indicators:
Market Capitalization AVITA Medical|RCEL - Value Adjusted for Debt and Cash
- book capitalization indicators:
Book Value per Share AVITA Medical|RCEL - Total Stockholders' Equity|Market Value to Book Value Ratio avitamedical.com|RCEL - Aggregate Asset Value
- company total debt and liquidity indicators:
Total Debt to Capital AVITA Medical, Inc.|RCEL - Long-Term Debt to Capital|Short-Term Debt to Equity AVITA Medical, Inc.|RCEL - Company Aggregate Indebtedness|Debts to Book Capitalization AVITA Medical|RCEL - Long-Term Debt|Company Current Liabilities AVITA Medical|Quick Liquidity Indicator avitamedical.com
- earnings and valuation multiples information:
RCEL - Profit After Payment of Taxes
Summary company analytics:AVITA Medical, RCEL
Finished products of AVITA Medical, Inc.

For AVITA Medical, Inc. (RCEL), which is developing the innovative RECELL skin regeneration system, the balance between debt and equity determines financial stability. This metric is calculated as the sum of all liabilities divided by shareholders' equity. By analyzing the ratio of total liabilities to equity, an investor assesses the business's degree of dependence on creditors. Low leverage allows the company to invest seamlessly in a high-paid staff of biomedical specialists, ensuring operational stability regardless of market volatility.

Competitors of AVITA Medical, Inc.

Total Debt to Equity Ratio DXCM|PEN (Penumbra Inc) - Aggregate Debt to Capital|Total Debt to Capital NOVT|HAE (Haemonetics Company) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital INSP (Inspire Medical Systems)|procept-biorobotics.com (PRCT) - Debt to Capital|CNMD - Debt to Equity|All Debt to Shareholders' Equity Ratio PLSE (Pulse Biosciences Inc)|INMD: Total Debt to Capital|Picard Group (PMI) - Total Debt to Capital|Debt to Equity Surmodics, Inc.|Senseonics Corp - Aggregate Debt to Equity|Total Debt to Capital NPCE|TCMD - Debt to Capital|SANUWAVE Health, Inc. - Total Debt to Equity Ratio|Total Debt to Capital Outset Medical Corp OM|ELMD: Total Debt to Equity Ratio|lensar.com - Aggregate Debt to Capital|PROF: Total Debt to Capital|BDMD - Total Debt to Capital Coefficient|EDAP (EDAP TMS SA) - Total Debt to Capital|Total Debt to Equity Ratio Bovie Medical (APYX)|Total Debt to Equity Ratio ICCM (IceCure Medical Ltd)|LUNG (pulmonx.com) - All Debt to Shareholders' Equity Ratio|Debt to Equity TELA Bio TELA|CTSO - Total Debt to Equity Ratio|Sensus Healthcare Corp - Total Debt to Capital|Debt to Capital Zynex Corp|ECOR: Total Debt to Capital|Debt to Equity Ratio RBOT|IINN (Inspira Technologies Oxy B.H.N. Ltd.) - Total Debt to Capital|SeaStar Medical Holding Corporation (ICU) - Total Debt to Capital Coefficient|Total Debt to Capital IRIX|Total Debt to Equity Ratio ibs.inc INBS|Total Debt to Capital XAIR (Beyond Air)|Total Debt to Capital profusa.com PFSA|SSKN - Debt to Equity|GCTK: Debt to Equity|NAOV (NanoVibronix) - Total Debt to Equity Ratio|Venus Concept Corporation - All Debt to Shareholders' Equity Ratio|NUWE (Nuwellis, Inc.) - Total Debt to Capital|Debt to Capital aethlonmedical.com AEMD|Debt to Equity Asensus Surgical, Inc. (ASXC)|Avinger Inc. (AVGR) - Debt to Capital Ratio|BioSig Technologies, Inc. - Total Debt to Equity Ratio|Total Debt to Capital Cutera Inc CUTR|Know Labs, Inc. - Total Debt to Capital|Total Debt to Capital Coefficient inarimedical.com NARI|Nevro (NVRO) - Debt to Equity|Aggregate Debt to Equity RSLS (ReShape Lifesciences Inc.)|Debt to Equity Silk Road Medical Inc.